Adagene Inc. Research and Development Expense
Adagene Inc. (ADAG) reported Research and Development Expense of $22.03 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-01
| Period end | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|
| 2025-12-31 | $22.03M 20-F · filed 2026-04-01 | |
| 2025-06-30 | $12.02M 6-K · filed 2025-08-12 | |
| 2024-12-31 | $28.78M 20-F · filed 2026-04-01 | |
| 2024-06-30 | $14.72M 6-K · filed 2025-08-12 | |
| 2023-12-31 | $36.64M 20-F · filed 2026-04-01 | |
| 2023-06-30 | $21.29M 6-K · filed 2024-07-25 | |
| 2022-12-31 | $81.34M 20-F · filed 2025-03-24 | |
| 2021-12-31 | $68.10M 20-F · filed 2024-03-29 | |
| 2020-12-31 | $33.54M 20-F · filed 2023-04-28 | |
| 2019-12-31 | $16.21M 20-F · filed 2022-04-26 | |
| 2018-12-31 | $16.08M 20-F · filed 2021-04-28 |